About Us
Boehringer Ingelheim is a global, research-driven pharmaceutical company that focuses on developing innovative therapies to improve the health and quality of life of patients. Founded in 1885, the company has grown to become one of the world's leading pharmaceutical companies, with a strong presence in human pharmaceuticals, animal health, and biopharmaceutical contract manufacturing.
Sustainability
Boehringer Ingelheim is committed to sustainability and has implemented various initiatives to reduce its environmental impact. The company publishes an annual ESG (Environmental, Social, and Governance) report that outlines its efforts in areas such as carbon footprint reduction, waste management, and sustainable sourcing. Boehringer Ingelheim has also received several sustainability certifications and accreditations, demonstrating its commitment to environmental stewardship.
- Reduction of carbon emissions through energy-efficient practices and renewable energy sources.
- Implementation of waste reduction programs and recycling initiatives.
- Sustainable sourcing of raw materials and ethical supply chain management.
- Commitment to social responsibility through various community and health initiatives.
For more detailed information, please visit the company's official website or refer to their latest ESG report.